Acyline
Acyline is a pharmaceutical drug with 14 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
92.9%
13 of 14 finished
7.1%
1 ended early
0
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cardiovascular Outcomes of Low Testosterone
ITT-5 Mechanisms of Spermatogenesis in Man
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Clinical Trials (14)
Cardiovascular Outcomes of Low Testosterone
ITT-5 Mechanisms of Spermatogenesis in Man
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
PROS-2 Dose Response Effects of Exogenous Testosterone on the Prostate
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
ORAL T-8 Oral Testosterone for Male Hormonal Contraception
CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men
ACY-7 Oral Administration of Acyline
ORAL T-6: Oral Androgens in Man-6
ACY-6 Oral Administration of Acyline
Male Hormonal Contraceptive Development-ACY-5
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
The Effects of Testosterone on Prostate Tissue (ACYP-1)
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14